Company
Headquarters: Irvine, CA, United States
Employees: 4
CEO: Mr. Joseph Michael Redmond
$8.3 Million
USD as of Jan. 1, 2024
Company | Market Cap (USD) |
---|---|
Abbott | $192.67 B |
Stryker Corporation | $113.24 B |
Medtronic | $111.60 B |
Boston Scientific Corporation | $85.22 B |
Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
Company | Market Cap (USD) |
---|---|
Lilly | $586.39 B |
UnitedHealth Group | $504.47 B |
Novo Nordisk | $461.52 B |
Johnson & Johnson | $387.50 B |
Merck | $296.51 B |
Odyssey Group International, Inc., a medical technology company, focuses on development, acquisition, and commercialization of medical products and health related technologies. It develops three lifesaving technologies, including CardioMap, a heart monitoring and screening device; Save A Life choking rescue device; and a neurosteroid drug compound intended to treat concussions and rare brain disorders. The company was founded in 2014 and is headquartered in Irvine, California.
Top 1-year algo backtest: +313.24%
$10,000 in May 2023 would now be $41,324 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Odyssey Group International, Inc. has the following listings and related stock indices.
Stock: OTC: ODYY wb_incandescent